295 related articles for article (PubMed ID: 19684511)
41. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm.
Hashikawa K; Niino D; Yasumoto S; Nakama T; Kiyasu J; Sato K; Kimura Y; Takeuchi M; Sugita Y; Hashimoto T; Ohshima K
J Am Acad Dermatol; 2012 Feb; 66(2):278-91. PubMed ID: 21835496
[TBL] [Abstract][Full Text] [Related]
43. Blastic plasmacytoid dendritic cell neoplasm.
Lim D; Goodman H; Rademaker M; Lamont D; Yung A
Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
[TBL] [Abstract][Full Text] [Related]
44. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
Ferran M; Gallardo F; Ferrer AM; Salar A; Pérez-Vila E; Juanpere N; Salgado R; Espinet B; Orfao A; Florensa L; Pujol RM
Br J Dermatol; 2008 May; 158(5):1129-33. PubMed ID: 18294313
[TBL] [Abstract][Full Text] [Related]
45. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract][Full Text] [Related]
46. [Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic study].
Sang W; Wang CF; Cheng YF; Liu X; Li XX; Gulinar A; Li JZ; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):326-30. PubMed ID: 22883672
[TBL] [Abstract][Full Text] [Related]
47. Morphologic characteristics of blastic plasmacytoid dendritic cell neoplasm: a case report.
Ru Y; Zhang P; Dong S; Wang H; Zhao S; Mi Y; Eyden B
Ultrastruct Pathol; 2014 Feb; 38(1):66-8. PubMed ID: 23957370
[TBL] [Abstract][Full Text] [Related]
48. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
[TBL] [Abstract][Full Text] [Related]
49. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
50. Blastic plasmacytoid dendritic cell neoplasm in a 7-year-old girl with a solitary skin lesion mimicking traumatic purpura.
Nomura H; Egami S; Kasai H; Yokoyama T; Fujimoto A; Sugiura M; Yagi H; Iwafuchi H; Kudo K
Acta Derm Venereol; 2015 Feb; 95(2):231-2. PubMed ID: 24909659
[No Abstract] [Full Text] [Related]
51. [Agranular CD4+ CD56+ CD123+ hematodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization: 2 cases].
Machet L; De Muret A; Wiezberka E; Bernez A; Abdallah-Lotf M; Linassier C; Petrella T
Ann Dermatol Venereol; 2004 Nov; 131(11):969-73. PubMed ID: 15602384
[TBL] [Abstract][Full Text] [Related]
52. Blastic plasmacytoid dendritic cell neoplasm: cytopathologic findings.
Zheng G; Schmieg J; Guan H; Ali SZ
Acta Cytol; 2012; 56(2):204-8. PubMed ID: 22378086
[TBL] [Abstract][Full Text] [Related]
53. Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.
Borchiellini D; Ghibaudo N; Mounier N; Del Giudice P; Quinsat D; Ticchioni M; Perrin C; Cardot Leccia N; Lacour JP
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1176-81. PubMed ID: 22455538
[TBL] [Abstract][Full Text] [Related]
54. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
[TBL] [Abstract][Full Text] [Related]
55. A case of cutaneous blastic plasmacytoid dendritic cell neoplasm.
Xue R; Wu T; Pan H; Gu Y; Yang B; Chen Y; Qiu J
Acta Derm Venereol; 2010 Nov; 90(6):645-6. PubMed ID: 21057756
[No Abstract] [Full Text] [Related]
56. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?
Dalle S; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dompmartin A; d'Incan M; Maubec E; Grange F; Dereure O; Prey S; Barete S; Wetterwald M; Fraitag S; Petrella T
Br J Dermatol; 2010 Jan; 162(1):74-9. PubMed ID: 19689477
[TBL] [Abstract][Full Text] [Related]
57. Blastic plasmacytoid dendritic cell neoplasm without cutaneous involvement: a rare disease with a rare presentation.
Dantas FE; de Almeida Vieira CA; de Castro CC; Neto GC; Matos DM
Acta Oncol; 2012 Jan; 51(1):139-41. PubMed ID: 21871006
[No Abstract] [Full Text] [Related]
58. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
59. Natural killer cell neoplasms.
Liang X; Graham DK
Cancer; 2008 Apr; 112(7):1425-36. PubMed ID: 18286525
[TBL] [Abstract][Full Text] [Related]
60. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
Garnache-Ottou F; Feuillard J; Saas P
Br J Haematol; 2007 Feb; 136(4):539-48. PubMed ID: 17367408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
